Current treatment approaches for brain metastases in ALK/ROS1/NTRK-positive non-small-cell lung cancer
Sign Up to like & getrecommendations! Published in 2022 at "Expert Review of Anticancer Therapy"
DOI: 10.1080/14737140.2023.2162044
Abstract: ABSTRACT Introduction Oncogene-addicted non-small cell lung cancer (NSCLC) patients present a high incidence of CNS metastases either at diagnosis or during the course of the disease. In this case, patients present with worse prognosis and… read more here.
Keywords: non small; alk ros1; ros1 ntrk; small cell ... See more keywords
Genomic Features of Solid Tumor Patients Harboring ALK/ROS1/NTRK Gene Fusions
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.813158
Abstract: The fusions of receptor tyrosine kinase (RTK) involving anaplastic lymphoma kinase (ALK), c-ros oncogene 1 (ROS1), and neurotrophic receptor tyrosine kinase (NTRK) represent the potential targets of therapeutic intervention for various types of solid tumors.… read more here.
Keywords: alk ros1; tumor patients; ros1 ntrk; genomic features ... See more keywords